VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $66,000 | -99.9% | 6,000 | +128.9% | 0.20% | +266.1% |
| Q3 2016 | $66,545,000 | +1286.4% | 2,621 | +336.8% | 0.06% | +1300.0% |
| Q2 2016 | $4,800,000 | -82.5% | 600 | -46.9% | 0.00% | -91.7% |
| Q1 2016 | $27,440,000 | +243.0% | 1,130 | +182.5% | 0.05% | +100.0% |
| Q3 2014 | $8,000,000 | -89.5% | 400 | -41.6% | 0.02% | -91.5% |
| Q2 2014 | $76,075,000 | – | 685 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |